US 12297186
Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5
granted A61KA61K31/4709A61K45/06
Quick answer
US patent 12297186 (Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5) held by AGOMAB SPAIN, S.L.U. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AGOMAB SPAIN, S.L.U.
- Grant date
- Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/4709, A61K45/06, A61P, A61P35/00